Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Comment by MrMonkon Aug 28, 2013 12:30pm
173 Views
Post# 21703623

RE:RE:RE:Soon we will know...

RE:RE:RE:Soon we will know...It probably is great news however who knows how the inventory community will interpret this - impossible to read people's minds.  On the one hand, they're now the sole owner of a property with 2MM+ ounces in a mining-friendly jurisdiction, and with cash in the till.  On the other hand, people might let their minds run wild with questions like "Why would Hecla/ARZ walk from this deposit if it's so good?  Something must be wrong with it...".  Can't read people, useless to even try.

You need to assess the situation and make your own judgement based on the best information that you have available (and with certain assumptions).  If you like this, hold on.  If you think it's bad news, sell your shares.  It's really that simply.

I personally like this development.  They are at an advanced stage now (relative to when they started with ARZ) and able to negotiate a much better deal with a new partner (I'm being told there is interest from others; whether that's true or not remains to be seen).  Gold shares are still in the dumps and I don't see a lot of downside here, but plenty of upside.  But that's just me.  You will have to decide for yourself.

Stock is up one penny...on 15,000 shares.  The stock will need a better news catalyst to attract buyers (and engage sellers).  Don't look at the penny rise, look at the number of shares traded.  Either everyone is on vacation, this news didn't come as a surprise, or it's not enough to get people off their arses...

-- MM







<< Previous
Bullboard Posts
Next >>